Studying depression using imaging and machine learning methods
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Depression is a complex clinical entity that can pose challenges for clinicians regarding both accurate diagnosis and effective timely treatment. These challenges have prompted the development of multiple machine learning methods to help improve the management of this disease. These methods utilize anatomical and physiological data acquired from neuroimaging to create models that can identify depressed patients vs. non-depressed patients and predict treatment outcomes. This article (1) presents a background on depression, imaging, and machine learning methodologies; (2) reviews methodologies of past studies that have used imaging and machine learning to study depression; and (3) suggests directions for future depression-related studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection
Kohavi, R. (1995) · Zenodo · doi:10.5281/zenodo.19712698 · Cited by 10,909
Top 10 algorithms in data mining
Wu, X., Kumar, V., Ross Quinlan, J., Ghosh, J., Yang, Q., Motoda, H., McLachlan, G. J., Ng, A., Liu, B., Yu, P. S., et al. (2008) · Knowledge and Information Systems · doi:10.1007/s10115-007-0114-2 · Cited by 5,667
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Identified biomarkers representing the biological substrates of MDD have been derived from multiple domains including neuroimaging, neuropsychological testing, genetics, and proteomics (Douglas and Porter, 2009; Laje et al., 2007; Miller et al., 2009).”
Diffusion tensor imaging: Concepts and applications
Le Bihan, D., Mangin, J., Poupon, C., Clark, C. A., Pappata, S., Molko, N., & Chabriat, H. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1076 · Cited by 3,547 · cited 1×
“Finally, fMRI images are used to study brain activity aswell as functional connectivity between different cortical regions by exploiting underlying blood flow (Le Bihan et al., 2001; Blink, 2004; Vink et al., 2007).”
A few useful things to know about machine learning
Domingos, P. (2012) · Communications of the ACM · doi:10.1145/2347736.2347755 · Cited by 3,326
Assessing the accuracy of prediction algorithms for classification: an overview
Baldi, P., Brunak, S., Chauvin, Y., Andersen, C. A. F., & Nielsen, H. (2000) · Bioinformatics · doi:10.1093/bioinformatics/16.5.412 · Cited by 2,111
Small sample size effects in statistical pattern recognition: Recommendations for practitioners
Raudys, S. J., & Jain, A. K. (1991) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/34.75512 · Cited by 1,384
Andrade, L., Caraveo‐anduaga, J. J., Berglund, P., Bijl, R. V., Graaf, R. D., Vollebergh, W., Dragomirecka, E., Kohn, R., Keller, M., Kessler, R. C., et al. (2003) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.138 · Cited by 1,068 · cited 1×
“Major depressive disorder has an estimated lifetime prevalence of approximately 17%, and has significant effects on quality of life, comorbid medical conditions, suicide risk, and healthcare utilization (Andrade et al., 2003).”
Zeng, L.-L., Shen, H., Liu, L., Wang, L., Li, B., Fang, P., Zhou, Z., Li, Y., & Hu, D. (2012) · Brain · doi:10.1093/brain/aws059 · Cited by 748 · cited 1×
“…(linear kernel) – Non-sparse L2-norm support vector machines (linear kernel) for comparisond Dataset 1 – Accuracya: 78.95% – Sensitivityb: 68.42% – Specificityc: 89.47% Dataset 2 – Accuracya: 85.00% – Sensitivityb: 83.33% – Specificityc: 86.67% Zeng et al. (2012) – 24 depressed – 29…”
InfluentialToward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561 · cited 1×
“…an initial attempt to model depression diagnosis and treatment response is in accordance with past neuroimaging-based studies that have predominantly found anatomical changes and altered brain activity to be valuable biomarkers of major depression (Dunlop and Mayberg, 2014; McGrath et al., 2013).”
A Review of Feature Reduction Techniques in Neuroimaging
Mwangi, B., Tian, T. S., & Soares, J. C. (2014) · Neuroinformatics · doi:10.1007/s12021-013-9204-3 · Cited by 559
White matter hyperintensities in late life depression: a systematic review
Herrmann, L. L., Le Masurier, M., & Ebmeier, K. P. (2007) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.124651 · Cited by 456
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
Resting-state functional connectivity in treatment-resistant depression
Lui, S., Wu, Q., Qiu, L., Yang, X., Kuang, W., Chan, R. C. K., Huang, X., Kemp, G. J., Mechelli, A., & Gong, Q. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10101419 · Cited by 336 · cited 1×
“Specifically, the utility of biomarkers is likely more valuable in the early identification of treatment non-response, as symptom remission is known to lag behind changes in underlying neural function (Aizenstein et al, 2014; Hsieh et al., 2002; Lui et al., 2011; Mayberg et al., 1997).”
Prognostic and diagnostic potential of the structural neuroanatomy of depression
Costafreda, S. G., Chu, C., Ashburner, J., & Fu, C. H. Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006353 · Cited by 232 · cited 1×
“…Features [Imaging modality] Feature reduction method Cross-validation method Machine learning method Results (Note: highest accuracies presented) Costafreda et al. (2009) – 9 responders – 9 non-responders – Smoothed gray matter voxel-based intensity values [T1-weighted] – Voxel based…”
Relation Between Structural and Functional Connectivity in Major Depressive Disorder
de Kwaasteniet, B., Ruhe, E., Caan, M., Rive, M., Olabarriaga, S., Groefsema, M., Heesink, L., van Wingen, G., & Denys, D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.12.024 · Cited by 229
Longitudinal Assessment of Neuropsychological Function in Major Depression
Douglas, K. M., & Porter, R. J. (2009) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048670903279887 · Cited by 217 · cited 1×
“Identified biomarkers representing the biological substrates of MDD have been derived from multiple domains including neuroimaging, neuropsychological testing, genetics, and proteomics (Douglas and Porter, 2009; Laje et al., 2007; Miller et al., 2009).”
Hippocampal volume and antidepressant response in geriatric depression
Hsieh, M., McQuoid, D. R., Levy, R. M., Payne, M. E., MacFall, J. R., & Steffens, D. C. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.611 · Cited by 136 · cited 1×
“Specifically, the utility of biomarkers is likely more valuable in the early identification of treatment non-response, as symptom remission is known to lag behind changes in underlying neural function (Aizenstein et al, 2014; Hsieh et al., 2002; Lui et al., 2011; Mayberg et al., 1997).”
Neuroimaging-based biomarkers for treatment selection in major depressive disorder
Dunlop, B. W., & Mayberg, H. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/bdunlop · Cited by 127 · cited 2×
“…an initial attempt to model depression diagnosis and treatment response is in accordance with past neuroimaging-based studies that have predominantly found anatomical changes and altered brain activity to be valuable biomarkers of major depression (Dunlop and Mayberg, 2014; McGrath et al., 2013).”
Steffens, D. C., Taylor, W. D., Denny, K. L., Bergman, S. R., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022697 · Cited by 73 · cited 1×
“This has prompted many groups to simultaneously investigate multiple neuroimaging domains in depression for the increased perspective it can afford (de Kwaasteniet et al., 2013; Khalaf et al., 2015; Steffens et al., 2011).”
Thase, M. E. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mthase · Cited by 57 · cited 1×
“Additionally, non-imaging measures have also been studied as potential biomarkers for depression and its treatment response (Lopresti et al., 2014; Thase, 2014).”
Cited by
Automated assessment of psychiatric disorders using speech: A systematic review
Low, D. M., Bentley, K. H., & Ghosh, S. S. (2020) · Laryngoscope Investigative Otolaryngology · doi:10.1002/lio2.354 · Cited by 509
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
Machine learning in major depression: from classification to treatment outcome prediction
Gao, S., Calhoun, V. D., & Sui, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13048 · Cited by 370
Multimodal mild depression recognition based on EEG-EM synchronization acquisition network
Zhu, J., Wang, Y., La, R., Zhan, J., Niu, J., Zeng, S., & Hu, X. (2019) · IEEE Access · doi:10.1109/access.2019.2901950 · Cited by 56
“Furthermore, there is evidence that indicates that a Linear SVM is often selected for classification if the data size is insufficiently large, because a Linear SVM might be beneficial in avoiding overfitting as well as realizing good classification performance and robustness [66], [67].”
BackgroundRichter, T., Fishbain, B., Richter-Levin, G., & Okon-Singer, H. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100957 · Cited by 52
Metadata
- Authors
- Patel, M. J., Khalaf, A., & Aizenstein, H. J.
- Venue
- NeuroImage: Clinical
- Publisher
- Elsevier BV
- Published
- 2016
- Volume
- 10
- Pages
- 115-123
- ISSN
- 2213-1582 (ISSN-L)
- OpenAlex
- W2412208823
- Cited by
- 178
- References
- 21
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.